期刊文献+

拜颤停复方对帕金森病模型小鼠神经炎症的影响 被引量:8

Effects of Baichanting Compound on Neuroinflammatory Responses in Mice Models with Parkinson's Disease
下载PDF
导出
摘要 目的探讨拜颤停复方对帕金森病(PD)模型小鼠神经保护作用的免疫炎症机制。方法腹腔注射1-甲基-4-苯基-1,2,3,6-四氢吡啶30 mg/(kg·d),连续5 d,诱导雄性C57BL/6小鼠制作PD模型。将实验小鼠随机分为正常组、模型组及拜颤停复方组,造模后第6日治疗组给予拜颤停复方181.50 mg/(kg·d)灌胃,连续20 d。通过爬杆实验及自主活动实验进行小鼠神经行为学观察,应用UPLC-MS-MS三重四级杆串联质谱仪检测小鼠纹状体多巴胺(DA)含量,ELISA检测中脑黑质部位炎症因子白细胞介素(IL)-1β、IL-6、肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)及一氧化氮(NO)的水平。结果与正常组比较,模型组小鼠爬杆时间显著延长、自主活动次数及纹状体DA含量显著降低,IL-1β、IL-6、TNF-α、IFN-γ及NO水平均显著升高;与模型组比较,拜颤停复方组可显著缩短爬杆时间、增加自主活动次数及纹状体DA含量,显著降低各炎症因子及NO水平(P<0.05,P<0.01)。结论拜颤停复方可明显改善PD小鼠的神经行为学变化,降低小鼠中脑黑质炎症因子及NO水平,保护神经元。 Objective To discuss the immune inflammation mechanism of neuroprotective potential of Baichanting Compound on mice models with Parkinson's disease(PD). Methods The PD model mice were induced by intraperitoneal injecting MPTP 30 mg/(kg·d) for 5 days in male C57BL/6 mice. The mice were randomly divided into control group, model group and Baichanting Compound group. From the sixth day after modeling, Baichanting Compound group was given Baichanting Compound 181.50 mg/(kg·d) orally for gavage for 20 days. The pole and independent activity experiments were used to observe the neuroethology of mice. DA content in corpus striatum was detected by UPLC-MS-MS. The levels of inflammation factors, such as IL-1β, IL-6, TNF-α, IFN-γ and NO in midbrain nigra tissues were detected by ELISA. Results Compared with the control group, the time of climbing pole was significantly prolonged;the number of independent activities and DA content in corpus striatum decreased significantly;the levels of IL-1β, IL-6, TNF-α, IFN-γ and NO significantly increased in PD mice in the model group. Compared with model group, the time of climbing pole was shortened obviously;the number of independent activities and DA content in corpus striatum increased significantly;the levels of IL-1β, IL-6, TNF-α, IFN-γ and NO decreased significantly in PD mice in the Baichanting Compound group. Conclusion Baichanting Compound can improve neurobehavioral changes in PD mice obviously by reducing inflammation factors and NO level in substantia nigra to protect neurons.
出处 《中国中医药信息杂志》 CAS CSCD 2015年第12期68-71,共4页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家自然科学基金青年基金(81303249) 黑龙江省博士后资助项目(LBH-Z11017)
关键词 帕金森病 拜颤停复方 炎症因子 一氧化氮 小鼠 Parkinson's disease Baichanting Compound inflammation factor NO mice
  • 相关文献

参考文献13

二级参考文献76

  • 1梁庆成,王凤平,王维治.帕金森病与肿瘤坏死因子-α[J].国外医学(神经病学.神经外科学分册),2004,31(4):325-328. 被引量:3
  • 2朱蔚文,刘焯霖,徐浩文,褚文政,叶钦勇,谢安木,陈玲,黎锦如.灵芝孢子油对MPTP处理小鼠行为学及黑质区病理变化的影响[J].第一军医大学学报,2005,25(6):667-671. 被引量:16
  • 3牛朝诗,李健.立体定向技术注射6-OHDA至内侧前脑束建立帕金森病大鼠模型[J].立体定向和功能性神经外科杂志,2007,20(1):19-24. 被引量:10
  • 4Grunblatt E,Mandel S,Maor G,Youdim MB.Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray:effect of R-apomorphine.J Neurochem 200t,78:1-12.
  • 5Di Monte DA.The environment and Parkinson's disease:is the nigrostriatal system preferentially targeted by neurotoxins?Lancet Neurol 2003,2:531-538.
  • 6Vila M,Przedborski S.Genetic clues to the pathogenesis of Parkinson's disease.Nat Med 2004,10 suppl:S58-S62.
  • 7Schapira AH.Etiology of Parkinson's disease.Neurology 2006,66 (10 Suppl 4):S10-S23.
  • 8Barnham KJ,Masters CL,Bush AI.Neurodegenerative diseases and oxidative stress.Nat Rev Drug Discov 2004,3:205-214.
  • 9Weber CA,Ernst ME.Antioxidants,supplements,and Parkinson's disease.Ann Pharmacother 2006,40:935-938.
  • 10Hald A,Lotharius J.Oxidative stress and inflammation in Parkinson's disease:is there a causal link? Exp Neurol,2005,193:279-290

共引文献39

同被引文献112

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部